Evidence map›Paper›PMID 35445197›Full record

ArticleMaterials advances2022

High affinity zoledronate-based metal complex nanocrystals to potentially treat osteolytic metastases.

Gabriel Quiñones Vélez, Lesly Carmona-Sarabia, Alondra A Rivera Raíces, Tony Hu, Esther A Peterson-Peguero, Vilmalí López-Mejías

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Functionalization of Titanium Dioxide byInorganic chemistry · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gabriel Quiñones VélezDepartment of Chemistry, University of Puerto Rico Río Piedras San Juan Puerto Rico 00931 USA vilmali.lopez@upr.edu.ORCID https://orcid.org/0000-0001-8789-1616
Lesly Carmona-SarabiaDepartment of Chemistry, University of Puerto Rico Río Piedras San Juan Puerto Rico 00931 USA vilmali.lopez@upr.edu.ORCID https://orcid.org/0000-0002-1733-319X
Alondra A Rivera RaícesCrystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico San Juan Puerto Rico 00926 USA.ORCID https://orcid.org/0000-0002-7250-5345
Tony HuDepartment of Chemistry and the Molecular Design Institute, New York University 100 Washington Square East New York New York 10003-6688 USA.ORCID https://orcid.org/0000-0002-8172-2202
Esther A Peterson-PegueroDepartment of Biology, University of Puerto Rico, Río Piedras San Juan Puerto Rico 00931 USA.ORCID https://orcid.org/0000-0001-7497-0980
Vilmalí López-MejíasDepartment of Chemistry, University of Puerto Rico Río Piedras San Juan Puerto Rico 00931 USA vilmali.lopez@upr.edu.ORCID https://orcid.org/0000-0003-2138-8414

Funding

Upgrade Laboratories Facilities at UPR-Rio PiedrasR25GM061151 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2001 to 2023
$32.5M
Design of Phosphonate-based Coordination Polymers as Targeted MultidrugDelivery Systems for Bone TherapySC2GM127223 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI LOPEZ-MEJIAS, VILMALI · 2020 to 2021
$224k
NIGMS NIH HHS R25 GM061151NIGMS NIH HHS SC2 GM127223
6 · The paper itself

Abstract

Formation of several materials, denoted as bisphosphonate-based coordination complexes (BPCCs), resulted from the reaction between clinically employed bisphosphonate, zoledronate (ZOLE) and bioactive metals (M

Identifiers

PMID35445197
PMCPMC8978309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.